Vivex Biomedical, Inc., a Marietta, GA-based biomaterials manufacturer and developer, completed a $7.6m first round of private equity financing.
Backers remained undisclosed.
The company intends to use the funds to refine current and develop new products, expand its team, and identify and pursue strategic partnerships and other opportunities.
Founded in 2013 as a spin-off of the biomaterials division of Amendia, Inc., a spinal implant manufacturer, Vivex is developing the MIAMI stem cell and mimetic pattern implants and other protected Intellectual Property. The company’s core biomaterials include demineralized bone matrix, sponge, allograft, and calcium phosphate products backed by a proprietary cleansing process that sustains bioactivity.
Vivex is led by Tracy Anderson, President and CEO.